Contact
Please use this form to send email to PR contact of this press release:
MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial – Hagens Berman
TO:
Please use this form to send email to PR contact of this press release:
MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial – Hagens Berman
TO: